Bristol-Myers' deepens focus on fibrosis with Nitto deal

Nov 10 (Reuters) - Bristol-Myers Squibb Co said on

Thursday it agreed to pay Japan's Nitto Denko Corp $100

million up front for the right to its early-stage drug for liver

fibrosis due to fatty...

Read more